
*Diffusion index: The difference between the percentage of companies reporting “excessive” employment minus those responding “insufficient”
†For example, according to a Euklems & INTANProd database of human capital investment as a share of GDP in leading industrialized countries, since the late 1990s Japan has been consistently well below the US, UK, France, Germany, and Italy


*Data covers 2005–2022 for approximately 1,400 companies listed on the TSE with available time series data on ESG disclosure scores and financial indicators such as value-added and P/B supplied by Bloomberg
†Our analysis used the social or S portion (covering human capital, diversity, health and safety) of the ESG scores provided by Bloomberg as a proxy for human capital investment. For financial performance, we selected two indicators: (1) real value-added (derived from financial statements on operating profit and depreciation in real terms using a GDP deflator) and (2) P/B (share price/net assets)
‡These results are consistent with previous research. For example, Ryohei Yanagi, Visiting Professor at Waseda University Graduate School of Accountancy, quantified the results of non-financial investments by Japanese pharma companies. He found it takes five–ten years for the results of investment become apparent
§The Financial Services Agency’s Progress Report on Enhancing Asset Management Business, 2022 edition, points out that when considering ESG (including human capital investment) fund managers should identify the important ESG elements at the investee. The FSA added that fund managers should develop frameworks for effectively analyzing and identifying potential business opportunities and risks that could affect corporate value by building and improving assessment systems using their own ESG scores